Sabadell Asset Management, S.A S.G.I.I.C Dr Reddys Laboratories LTD Transaction History

Sabadell Asset Management, S.A S.G.I.I.C

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jan 23, 2024	SELL	$49.62 - $58.13 $1.13 Million - $1.32 Million	-22,685 Closed	0 $0
Q4 2021 Jan 23, 2024	BUY	$59.5 - $67.25 $654,500 - $739,750	11,000 Added 94.14%	22,685 $1.44 Billion
Q2 2021 Jan 23, 2024	BUY	$62.12 - $74.2 $725,872 - $867,027	11,685 New	11,685 $859 Million

245

23.1M

12.7K

6.1K

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.55B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

Get notified when there are updates to the investment portfolio of Sabadell Asset Management, S.A S.G.I.I.C, based on Form 13F filings with the SEC.

Stay updated on Sabadell Asset Management, S.A S.G.I.I.C with notifications on news.